SA
FOLD

Sanctuary Advisors’s Amicus Therapeutics FOLD Stock Holding History

Sanctuary Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,445
Closed -$138K – 2545
2024
Q2 		$138K Buy
+13,445
New +$138K ﹤0.01% 2226

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sanctuary Advisors's FOLD Position: Q3 2024 in Review

Sanctuary Advisors sold out of Amicus Therapeutics (FOLD) in Q3 2024, closing a stake of 13,445 shares — an estimated $138K sold.

Sanctuary Advisors first reported a position in FOLD in Q2 2024 and held it in 1 quarter. The position peaked at $138K in Q2 2024. 293 funds tracked by Wall St. Rank hold FOLD as of Q3 2024.

  • Sanctuary Advisors reported no remaining Amicus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Sanctuary Advisors sold 13,445 Amicus Therapeutics shares in Q3 2024, an estimated $138K.
  • Sanctuary Advisors first reported a position in Amicus Therapeutics in Q2 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Amicus Therapeutics position peaked at $138K in Q2 2024.
  • 293 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2024.

Based on Sanctuary Advisors's 13F filing for Q3 2024, filed 25 Nov 2024.